Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

QVA149

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Background The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Highly Cited
2015
Highly Cited
2015
RATIONALE Current Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy recommends the combination of two long… Expand
Highly Cited
2014
Highly Cited
2014
INTRODUCTION QVA149 is a novel, inhaled, once-daily dual bronchodilator containing a fixed-dose combination of the long-acting β2… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Highly Cited
2013
Highly Cited
2013
BACKGROUND We evaluated the effect of dual, longacting inhaled bronchodilator treatment on exacerbations in patients with severe… Expand
Highly Cited
2013
Highly Cited
2013
We investigated the efficacy and safety of dual bronchodilation with QVA149 versus its monocomponents indacaterol and… Expand
Highly Cited
2013
Highly Cited
2013
BACKGROUND QVA149 is an inhaled fixed-dose combination therapy under development for the treatment of chronic obstructive… Expand
Highly Cited
2013
Highly Cited
2013
We evaluated the effect of QVA149, a dual bronchodilator combining indacaterol and glycopyrronium, on direct patient-reported… Expand
Highly Cited
2013
Highly Cited
2013
BACKGROUND QVA149 is an inhaled, once-daily fixed-dose dual bronchodilator combination of the long-acting β2-agonist indacaterol… Expand
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 2
Highly Cited
2010
Highly Cited
2010
Background This randomised, double-blind, placebo controlled, four-period crossover study assessed the efficacy and safety of… Expand
Highly Cited
2010
Highly Cited
2010
ABSTRACT This study assessed the cardiovascular safety of QVA149, an inhaled, once daily, bronchodilator combination containing… Expand